PubRank

J Simony-Lafontaine

Author PubWeight™ 31.69‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Eosinophilic inflammation in asthma. N Engl J Med 1990 8.05
2 Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 2001 2.51
3 Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups. Cancer Res 1997 2.22
4 Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol 1993 1.91
5 p53 mutations occur in aggressive breast cancer. Cancer Res 1992 1.43
6 Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas. Cancer Res 1997 1.33
7 Proto-oncogene amplification and human breast tumor phenotype. Oncogene 1989 1.27
8 Amplification of FGF-related genes in human tumors: possible involvement of HST in breast carcinomas. Oncogene 1989 1.12
9 Cell proliferation in the bronchial mucosa of asthmatics and chronic bronchitics. Am J Respir Crit Care Med 1994 1.03
10 Cathepsin D assay in primary breast cancer and lymph nodes: relationship with c-myc, c-erb-B-2 and int-2 oncogene amplification and node invasiveness. Eur J Cancer 1990 0.94
11 p53 status and response to radiotherapy in rectal cancer: a prospective multilevel analysis. Br J Cancer 2005 0.93
12 [Recommendations for the immunohistochemical evaluation of hormone receptors on paraffin sections of breast cancer. Study Group on Hormone Receptors using Immunohistochemistry FNCLCC/AFAQAP. National Federation of Centres to Combat Cancer/French Association for Quality Assurance in Pathology]. Ann Pathol 1996 0.91
13 Index for spatial heterogeneity in breast cancer. J Microsc 2004 0.87
14 Oxidant-antioxidant status alterations in cancer patients: relationship to tumor progression. J Nutr 1996 0.84
15 Variation of bcl-2 expression in breast ducts and lobules in relation to plasma progesterone levels: overexpression and absence of variation in fibroadenomas. J Pathol 1997 0.84
16 Tumor progression and oxidant-antioxidant status. Cancer Lett 1997 0.80
17 Quantification of ERBB2 protein expression in breast cancer: three levels of expression defined by their clinico-pathological correlations. Oncol Res 1994 0.80
18 Decrease of c-erbB-2 and c-myc RNA levels in tamoxifen-treated breast cancer. Oncogene 1991 0.79
19 [HER2 gene amplification assay: is CISH an alternative to FISH?]. Ann Pathol 2003 0.77
20 Potential value of increased MYC but not ERBB2 RNA levels as a marker of high-risk mastopathies. Oncogene 1993 0.77
21 Distribution of T-cell receptor-bearing lymphocytes in the synovial membrane from patients with rheumatoid arthritis. J Autoimmun 1990 0.77
22 [Histiocytic necrotizing lymphadenitis or Kikuchi's disease. Four cases]. Presse Med 1992 0.75
23 Prognostic factors of carcinoid tumor of the appendix smaller than two centimeters. Surgery 1993 0.75
24 [2002 Standards, Options and Recommendations: good practice for the management and shipment of histological and cytopathological cancer specimens]. Ann Pathol 2003 0.75
25 [Primary angiosarcoma of the breast. Apropos of 2 cases]. Bull Cancer 1997 0.75
26 [Appendiceal carcinoid tumor of systematic detection. When to propose right hemi-colectomy and how to monitor? Thoughts apropos of a case and review of the literature]. Ann Chir 1992 0.75
27 Tumor cell membrane as a potential target for methyl-beta-cyclodextrin. Anticancer Res 1998 0.75
28 T cell receptor distribution in rheumatoid synovial follicles. J Rheumatol 1995 0.75
29 [Positive sentinel node biopsy in breast cancer: is axillary surgery necessary in all cases?]. Bull Cancer 2007 0.75